Oral administration of branched-chain amino acids ameliorates high-fat diet-induced metabolic-associated fatty liver disease via gut microbiota-associated mechanisms

Oral administration of branched-chain amino acids ameliorates high-fat diet-induced metabolic-associated fatty liver disease via gut microbiota-associated mechanisms

Branched-chain amino acids (BCAAs), essential amino acids for the human body, are mainly obtained from food. High levels of BCAAs in circulation are considered as potential markers of metabolic-associated fatty liver disease (MAFLD) in humans. However, there are conflicting reports about the effects...

Full description

Bibliographic Details
Main Authors: Ranran Zhang, Hongna Mu, Ziyun Li, Jie Zeng, Qi Zhou, Hongxia Li, Siming Wang, Xianghui Li, Xianghui Zhao, Liang Sun, Wenxiang Chen, Jun Dong, Ruiyue Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Microbiology
Subjects:
branched-chain amino acids
metabolic-associated fatty liver disease
lipometabolism
gut microbiota dysbiosis
branched-chain amino acids metabolism
LC–MS/MS
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.920277/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2022.920277/full

Similar Items